Novo Nordisk Foundation

Novo Nordisk Foundation

Non-profit-Organizations

Hellerup, Capital Re...
Denmark
Company Tagline

Benefitting People and Society

Industry Category
Non-profit-Organizations
Company Description

The Novo Nordisk Foundation is dedicated to significantly contributing to research and development, enhancing the lives of people and promoting societal sustainability. As an independent Danish enterprise foundation, The Novo Nordisk Foundation supports philanthropic endeavors through funds derived from its ownership and investments in various companies and financial assets. Operating independently, the Foundation focuses solely on its defined objectives.

Located at Tuborg Havnevej 19, Hellerup, Capital Region 2900, DK, The Novo Nordisk Foundation strives to provide a stable foundation for the commercial and research activities of the companies within the Novo Group, including Novo Nordisk A/S and Novozymes A/S. In addition to this, the Foundation actively supports a wide range of scientific, humanitarian, and social causes, reflecting its commitment to broader societal well-being.

The Novo Nordisk Foundation is continuously evolving its initiatives to maximize its positive impact. Management is diligently working to complete and update detailed information to further showcase the foundation's extensive contributions. We invite the manager of The Novo Nordisk Foundation to create a customized and exclusive company showcase and product listing on our platform to highlight these advancements and connect with a wider audience.

La Fondation Novo Nordisk se consacre à contribuer de manière significative à la recherche et au développement, améliorant ainsi la vie des personnes et favorisant la durabilité sociétale. En tant que fondation d'entreprise danoise indépendante, la Fondation Novo Nordisk soutient des initiatives philanthropiques grâce à des fonds provenant de sa propriété et de ses investissements dans diverses entreprises et actifs financiers. Opérant de manière indépendante, la Fondation se concentre uniquement sur ses objectifs définis.

Située à Tuborg Havnevej 19, Hellerup, Capital Region 2900, DK, la Fondation Novo Nordisk s'efforce de fournir une base stable pour les activités commerciales et de recherche des entreprises au sein du groupe Novo, notamment Novo Nordisk A/S et Novozymes A/S. De plus, la Fondation soutient activement un large éventail de causes scientifiques, humanitaires et sociales, reflétant son engagement envers le bien-être sociétal au sens large.

La Fondation Novo Nordisk fait constamment évoluer ses initiatives pour maximiser son impact positif. La direction travaille avec diligence pour compléter et mettre à jour des informations détaillées afin de mieux présenter les vastes contributions de la fondation. Nous invitons le responsable de la Fondation Novo Nordisk à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence ces avancées et de se connecter avec un public plus large.

Key Personnel / Employees
Flemming Konradsen Kurt Mathiesen Lasse Kristiansen (Strategy │ Innovation │ Technology) Mette Damgaard Nielsen (PhD Senior Scientific Manager - Biotech - Novo Nordisk Foundation) Stina Bjerg Nielsen (Founder and CEO at GLYSIOUS | CHRO Executive)

Similar Companies

Other organizations in the same industry

Youth Development Association (YDA)
Non-profit-Organizations

We aspire to push the students to put their best into everything they set their minds to.

Riyadh, Riyadh
Saudi Arabia
Hasbara Fellowships
Non-profit-Organizations

Empowering advocates for Israel on college & university campuses around North America.

New York, New York
United States
CogIST
Non-profit-Organizations

Unite, and Cognize!

IEEE CS Kerala Chapter
Non-profit-Organizations

Official LinkedIn page of IEEE CS Kerala Chapter

Alternative Company Names

This company is also known as

Novo Nordisk Foundation 诺和诺德基金会 नोवो नॉर्डिस्क फाउंडेशन Fundación Novo Nordisk مؤسسة نوفو نورديسك Fondation Novo Nordisk Фонд Ново Нордиск Fundação Novo Nordisk